Should You Buy These High-Yielding Shares? HSBC Holdings plc, AstraZeneca plc & Laura Ashley Holdings plc

Are HSBC Holdings plc (LON:HSBA), AstraZeneca plc (LON:AZN) and Laura Ashley Holdings plc (LON:ALY) attractive dividend shares?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investors need to beware of dividend yield traps when looking at high-yielding shares. Although high yields are tempting to income investors, they could also be a sign of potential dividend cuts or that a share price that has further to fall.

HSBC Holdings

HSBC (LSE: HSBA) (NYSE: HSBC.US) announced further cost cuts last week, with the bank now targeting annual cost savings of as much as $5 billion by 2017. To achieve this, HSBC will need to cut its workforce by almost a fifth and shed at least a quarter of its risk-weighted assets.

The bank has said that it is looking to sell its businesses in Brazil and Turkey; but is its management being radical enough. HSBC still has many underperforming businesses as the bank is spread so thinly across too many countries. Yet yesterday, CEO Steven Gulliver said HSBC will not sell its Mexican business, despite its limited presence there. 

Although HSBC’s dividend is likely to remain well covered in the medium term, profitability is likely to remain weaker than its peers. HSBC has lowered its return on equity (ROE) target from 12-15% to more than 10%.

Mr Gulliver now expects that the bank will only meet its ROE target by 2017. But, with much of the restructuring yet to come, profitability could get even worse. Although HSBC has a forward dividend yield of 5.4%, HSBC will likely continue to underperform domestically focused banks.

AstraZeneca

AstraZeneca (LSE: AZN) (NYSE: AZN.US) has a strong development pipeline of 119 projects, with between 8 and 10 projects expected to get regulatory approval by 2016.

Revenues and earnings are likely to remain subdued in the medium term, as new products are unlikely to offset the declining sales from blockbuster drugs. Crestor and Nexium, along with other legacy drugs that have already lost patent protection, should see their revenue decline accelerate as more generic alternatives become more available.

The company trades at a forward P/E of 15.2, with a prospective dividend yield of 4.4%. Dividend cover is expected to be 1.49x. Longer term, though, AstraZeneca’s earnings should bottom out as most of its pipeline of drugs are in the earlier stages of development.

Laura Ashley

Laura Ashley (LSE: ALY) pays a very attractive dividend yield of 6.6%, with expectations that the company will continue to pay a dividend of 2.0 pence per share. Excluding the special dividend paid in 2014, the company has paid 2.0 pence per share since 2012, even as the dividend was not fully covered by earnings. This has caused a run-down of its cash pile, which now stands at £27.8 million.

In 2014, total revenue rose 3.1% to £303.6 million, with adjusted pre-tax profit rising 18.7% to £22.9 million. The brand’s UK operations remain weak, and the company reduced its store count from 209 to 205. Licensing and international growth is performing more strongly, and should continue to be the main driver of growth in the medium term.

Looking forward, analysts expect earnings will recover significantly this year, after an already strong performance in 2014. Its shares trade at a forward P/E of 10.5, and its expected dividend cover is 1.5x. This should mean that the dividend is well covered, and there is potential for dividend increases in the longer term. Given its strong balance sheet and compelling earnings outlook, Laura Ashley is an attractive income stock.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Tang has no position in any shares mentioned. The Motley Fool UK has recommended HSBC Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »